Fact CheckerSign in

NCT04276194Completed

Vertebral Body Sparing Craniospinal Irradiation for Pediatric Patients With Cancer of the Central Nervous System

Feasibility of Vertebral Body Sparing Intensity Modulated Proton Therapy Craniospinal Irradiation With in Vivo Range Verification in Growing Children

Source: ClinicalTrials.gov · Last updated 21 Mar 2024

Brief summary (registry, in English)

This trial studies the feasibility of using intensity modulated proton therapy to deliver craniospinal irradiation while avoiding the bones of the vertebral column. Intensity modulated proton therapy is an advanced radiation therapy modality that uses high energy protons to kill cancer cells and shrink tumors, and may reduce the side effects of treatment by reducing radiation exposure to the spinal column.

Status (registry)
Completed
Study type
Interventional
Enrollment
10 (actual)
First submitted
27 Jan 2020
Start date
16 Dec 2019
Primary completion date
3 Nov 2021
Lead sponsor
Emory University
NCT number
NCT04276194

What you commit to

  • Study type: Interventional
  • Participants enrolled: 10
  • From 16 Dec 2019 to the primary completion date, 3 Nov 2021
  • 2 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Pregnant females are excluded. Females of childbearing age/menstruating must confirm that either they are not sexually active or have a negative pregnancy test prior to initiation of radiation therapy.

Other illness

  • Any contraindication to undergoing MRI (ferromagnetic implants such as aneurysm clips, surgical clips, prostheses, artificial cardiac valves or devices, electrical implants such as cardiac pacemakers or perfusion pumps). Metal fragments, shrapnel, or tattoos near the eye.
  • Any major uncontrolled or poorly controlled current illness that would limit compliance with study requirements.

Who the study is looking for

  • Pathologic diagnosis of central nervous system malignancy requiring craniospinal irradiation.
  • Signed informed consent and assent when indicated.

Age in the registry: 3 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (2)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Emory University Hospital/Winship Cancer Institute
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status
Emory Proton Therapy Center
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.